Fortress Biotech FBIO Cash Flow Statement (2010-2026)

NASDAQ FBIO
$1.94 +0.07 (+3.74%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Fortress Biotech Quarterly Cash Flow Statement

Periods 63 quarters
Latest Jun 2026

Fortress Biotech cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 63 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-24.39M-45.86M-68.51M-49.48M-53.93M-53.06M-57.45M-55.15M-59.30M-10.72M-28.98M-39.02M-28.82M-26.69M-26.32M-24.69M-11.65M8.83M-5.40M0.60M
Depreciation and DepletionDep. & Depletion
0.60M0.70M0.73M0.74M0.80M0.80M0.81M0.84M0.80M0.40M0.33M0.40M0.40M0.10M0.14M0.13M0.10M0.10M0.09M0.10M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.74M0.66M0.49M1.02M1.02M1.02M1.23M1.07M1.07M0.81M0.85M0.81M0.81M0.81M0.98M1.07M1.06M1.06M1.11M0.97M
Amortization of Deferred ChargesAmort. Deferred Charges
0.59M0.72M2.29M0.39M0.56M0.55M0.57M0.64M1.22M0.66M0.51M0.61M0.76M0.39M0.30M0.30M0.45M0.32M0.34M
Depreciation & Amortization (CF)Dep. & Amort.
0.60M0.70M0.73M0.74M0.80M0.80M0.81M0.84M0.80M0.40M0.33M0.40M0.40M0.10M0.14M0.13M0.10M0.10M0.09M0.10M
Share-based CompensationStock Comp.
4.35M4.33M7.04M5.56M5.08M6.84M5.51M4.73M4.22M4.38M3.70M4.86M5.00M6.57M16.19M6.29M16.79M3.20M2.46M2.88M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
-0.02M1.35M0.12M
Gains from Investment SecuritiesGains Investment
25.01M8.38M10.75M
Asset Writedowns and ImpairmentWritedown
3.14M-3.14M5.79M1.04M
Other non-cash itemsOther Non-Cash
15.44M1.30M1.15M0.57M0.70M0.83M0.44M-1.71M9.31M-10.04M6.77M0.63M1.42M3.60M0.91M0.33M0.40M0.18M0.83M
Change in Working Capital
Change in ReceivablesChange Receivables
2.05M5.54M-8.51M8.00M-2.48M-0.08M-0.05M-0.47M-10.43M-8.83M7.18M-5.42M0.81M0.88M-0.75M7.99M-2.82M2.42M11.76M
Change in InventoryChange Inventory
12.02M-2.70M-1.75M0.23M-0.08M-0.82M-1.07M-0.88M-1.11M-1.14M-0.82M0.37M-0.89M2.10M2.64M-1.94M0.36M-1.03M-2.19M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
8.29M28.12M9.35M2.19M2.01M0.21M3.94M4.77M-4.34M-17.45M-7.36M2.67M-4.80M-4.99M0.73M0.55M-8.37M-2.83M2.68M
Change in TaxesChange Taxes
0.35M0.00M0.00M0.01M0.36M0.00M0.08M0.04M-0.04M0.04M0.08M0.02M0.03M0.02M-0.65M
Change in Other Operating AssetsOther Assets Change
-1.59M0.63M2.38M-1.52M-0.76M0.49M3.50M-0.73M-1.28M-0.07M3.77M1.42M-4.12M-2.13M4.50M-2.50M0.24M-2.18M2.55M
Change in Other Operating LiabilitiesOther Liabilities Change
-2.87M-1.70M-1.29M-1.13M-1.14M-0.91M-0.91M-0.71M-0.73M-0.94M-0.70M-0.63M-1.85M0.22M-0.15M0.59M-1.25M-2.52M-0.72M
Other Working Capital ChangesOther WC Changes
-1.28M-2.33M-3.67M0.38M-0.38M-1.40M-4.41M0.03M0.55M-0.87M-4.47M-2.05M2.27M2.35M-4.65M3.09M-1.49M-0.35M-3.27M
Cash from OperationsCash from Ops.
-34.46M-21.70M-38.70M-46.86M-41.42M-43.27M-47.84M-43.22M-33.29M-16.78M-34.94M-25.39M-21.84M-20.06M-12.91M-19.56M-27.56M-6.11M-12.54M
Investing Activities
Capital ExpendituresCapex
1.69M0.46M1.96M1.34M0.31M0.98M0.09M0.03M0.00M0.03M-1.40M
Sales of Property, Plant and EquipmentPP&E (Sale)
1.17M
Change in Property, Plant and EquipmentChange in PP&E
-1.69M-0.46M-1.96M-1.34M-0.31M-0.98M-0.09M-0.03M0.00M-0.03M1.40M1.17M
Change in IntangiblesChange Intangibless
2.75M7.08M1.55M-19.66M3.00M15.00M
Acquisitions
20.00M5.00M
Divestments
2.87M
Net of Acquisitions & DivestmentsNet Acquisitions
-20.00M-5.00M2.87M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-4.84M-7.54M53.35M-21.34M-0.31M-0.89M-0.39M-5.00M-2.04M5.00M-0.06M-15.00M1.17M6.09M2.87M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
7.00M42.13M-42.13M5.00M28.00M-28.00M28.00M33.72M-33.72M
Long-Term Debt RepaymentsLT Debt Repayment
1.00M2.50M16.64M2.81M1.00M4.05M27.95M43.38M11.00M0.63M0.63M0.63M
Non-Current Debt
-1.00M-2.50M-9.64M39.32M-42.13M5.00M0.05M-43.38M0.00M14.62M-0.05M5.00M-0.63M
Short-Term Debt issuancesST Debt Issuance
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-1.00M-2.50M-9.64M39.32M-42.13M5.00M0.05M-43.38M0.00M14.62M-0.05M5.00M-0.63M
Change in Capital Stock
Common Stock IssuedStock Issued
0.14M2.75M6.48M4.23M1.40M0.22M0.38M0.45M0.72M0.89M0.37M0.92M1.98M0.57M0.54M1.03M0.62M1.69M0.41M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
0.14M2.75M6.48M4.23M1.40M0.22M0.38M0.45M0.72M0.89M0.37M0.92M1.98M0.57M0.54M1.03M0.62M1.69M0.41M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.14M2.75M6.48M4.23M1.40M0.22M0.38M0.45M0.72M0.89M0.37M0.92M1.98M0.57M0.54M1.03M0.62M1.69M0.41M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.18M0.18M0.18M0.18M0.17M0.17M0.17M0.17M0.17M
Dividends Paid - PreferredDiv. Paid (Pref.)
2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M2.01M
Dividends Paid - Common and PrefferdDiv Paid (Total)
2.20M2.20M2.20M2.20M2.20M2.20M2.19M2.19M2.19M2.19M2.19M2.18M2.18M0.18M0.17M0.17M0.17M0.17M0.17M
Other financing activitiesOther financing
25.89M4.78M8.93M10.90M3.69M1.81M0.18M0.09M0.25M4.46M1.62M0.30M2.00M8.38M6.84M7.01M5.42M
Cash from Financing ActivitiesCash from Financing
24.40M6.97M38.94M49.96M2.99M3.75M18.62M22.19M-30.38M-2.69M43.62M27.86M14.27M2.71M25.81M52.14M4.52M15.07M5.71M
Additional items
Change in Cash
-14.91M-22.27M53.60M-18.23M-38.74M-40.42M-29.62M-26.03M-65.71M-14.47M8.62M2.47M-7.57M-17.35M-2.10M33.74M-16.95M11.83M-6.84M
Ending Cash Balance
Free Cash FlowFCF
-36.15M-22.16M-40.65M-48.20M-41.73M-44.25M-47.94M-43.22M-33.33M-16.78M-34.96M-25.39M-21.84M-18.66M-12.91M-19.56M-27.56M-6.11M-12.54M
Net Cash FlowNCF
-14.91M-22.27M53.60M-18.23M-38.74M-40.42M-29.62M-26.03M-65.71M-14.47M8.62M2.47M-7.57M-17.35M-2.10M33.74M-16.95M11.83M-6.84M
Interest Paid
1.67M1.69M1.89M1.56M2.43M2.61M2.82M2.89M2.25M1.46M1.36M1.66M1.88M1.87M1.76M3.32M0.60M1.75M1.71M
Income Taxes PaidTaxes Paid
0.50M0.16M0.33M0.11M0.06M1.30M-0.60M-0.10M0.05M0.04M-0.04M0.12M0.01M

Fortress Biotech Cash Flow Statement API

Pull Fortress Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FBIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY